The Duchenne Program at UMass Medical School provides 360-degree care for patients with DMD and their families. The center is also playing a lead role…
When it comes to developing new medicines for Duchenne, creating good drugs is of course paramount. It is also critical, however, to design good trials…
Goal: improve future decision-making in the selection of drugs to advance to clinical trials in Duchenne muscular dystrophy President and COO Laura with our partners…
Innovative device could power smaller, faster trials for Duchenne muscular dystrophy and open clinical trial participation to broader range of patients A key focus…
Are you participating in this year's Small Kids. BIG Change! program? Get excited — we've got something new for you! Introducing: SKBC Badges! Collect them…
The Duchenne Program at University of Massachusetts Medical School celebrated its first anniversary in July, and according to its founding director, pediatric neurologist Dr. Brenda…
Today, we are grateful and encouraged to announce that three of our partner organizations are throwing their weight — and some serious financial firepower —…
Last week, The New York Times ran this article about Duchenne. The story mentions the incredible breakthroughs that are currently taking place in the field, but it also highlights…